MYTESI
Active substance: crofelemer
TABLET, COATED · CROFELEMER 125 mg/1
United StatesActive
Marketing holder: Napo Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CROFELEMER · 125 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-dd9d-7f4d-8b34-17626d7a6087;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70564-802
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 70564-802 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70564-802 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70564-802 · Verified 2026-10-09 · open in source